Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples